Evidence map›Paper›PMID 30364563›Full record

ArticleInternational journal of care coordination2018

Surveillance for colorectal cancer survivors in an integrated safety-net health system in the United States.

Bijal A Balasubramanian, Katelyn K Jetelina, Michael Bowen, Noel O Santini, Simon Craddock Lee

Abstract read
In one paragraph

Article in International journal of care coordination, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Barriers and facilitators to integrated cancer care between primary and secondary care: a scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  2. Importance of primary care for underserved cancer patients with multiple chronic conditions.Journal of cancer survivorship : research and practice · 2023
    Article
  3. Follow-up surveillance among colorectal cancer survivors of different sexual orientations.Journal of cancer survivorship : research and practice · 2022
    Article
  4. What Survivorship Means to Liver Transplant Recipients: Qualitative Groundwork for a Survivorship Conceptual Model.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2021
    Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bijal A BalasubramanianUTHealth School of Public Health in Dallas, Dallas, TX.
Katelyn K JetelinaUTHealth School of Public Health in Dallas, Dallas, TX.
Michael BowenUniversity of Texas Southwestern Medical Center, Dallas, TX.
Noel O SantiniParkland Health & Hospital System, Dallas TX.
Simon Craddock LeeUniversity of Texas Southwestern Medical Center, Dallas, TX.

Funding

UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI MELANIE H. COBB · 2010 to 2026
$53.7M
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)UL1TR001105 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$24.5M
UT Southwestern Center of Patient-Centered Outcomes Research (PCOR)R24HS022418 · AHRQ · UT SOUTHWESTERN MEDICAL CENTER · PI HALM, ETHAN A · 2013 to 2017
$5.0M
Incorporating primary care factors into risk-stratified cardiovascular care for complex cancer survivorsR01CA203856 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI BALASUBRAMANIAN, BIJAL A., LEE, SIMON J. CRADDOCK · 2016 to 2020
$2.9M
Predicting Diabetes Risk Using Glucose DataK23DK104065 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI BOWEN, MICHAEL EDWARD · 2014 to 2018
$862k
AHRQ HHS R24 HS022418NCATS NIH HHS UL1 TR001105NCI NIH HHS P30 CA142543NCI NIH HHS R01 CA203856NIDDK NIH HHS K23 DK104065
6 · The paper itself

Abstract

introductionGuideline-recommended surveillance reduces likelihood of colorectal cancer (CRC) recurrence, yet surveillance rates are low in the United States (US). Little is known about CRC surveillance rates among patients without health insurance and their primary care clinicians/oncologists' attitudes towards surveillance care.

methodsA retrospective study of 205 patients diagnosed with Stage I-III CRC from 2008-2010 was conducted in an integrated system with a network of providers delivering care to patients lacking health insurance coverage. Surveillance patterns were characterized from medical records and logistic regression models examined correlates of guideline-concordant surveillance. 41 Parkland primary care physicians (PCPs) and 24 oncologists completed surveys to assess their attitudes and practices regarding CRC surveillance.

results38% of CRC patients received guideline-concordant surveillance; those with early stage cancers were less likely to receive surveillance (OR=0.35; 95 CI: 0.14, 0.87). PCPs and oncologists differed markedly on who is responsible for cancer surveillance care. 77% of oncologists responded that PCPs evaluated patients for cancer recurrence while 76% of PCPs responded that these services were either ordered by oncologists or shared with PCPs. 67% of oncologists said they rarely provide a treatment and surveillance care plan to survivors and over half said that they infrequently communicate with patients' other physicians about who will follow patients for their cancer and other medical issues. DISCUSSION: Care coordination between PCP and oncologist is needed to improve CRC surveillance. New models of shared care clearly delineating roles for oncologists and PCPs are needed to improve CRC survivorship care.

Indexed as

Colorectal canceroncologistsprimary care physicianssurveillance

Identifiers

PMID30364563
PMCPMC6197490

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.